2301 Crown Court—Irving, Texas 75038


Press Release


For Further Information:

For Immediate Release


Steve Brown, CFO


Tel: 972-893-4000





Royal BodyCare Reports Annual Results

Irving, Texas (March 9, 2005)—Royal BodyCare, Inc. (ROBE OTC:BB) today reported an increase in net sales to $19,361,000 and an increase in net earnings to $592,000, or $0.03 per share, in the year ended December 31, 2005, compared to net sales of $18,266,000 and net earnings of $537,000, or $0.03 per share, in the prior year.

At December 31, 2005, the Company reported backlog of $2,400,000 compared to backlog at the end of the prior year of $2,300,000.

Clinton Howard, CEO said, “We were pleased to be able to increase earnings even though we expensed approximately $180,000 in 2005 preparing to open a new wholly owned subsidiary, RBC Life Sciences Korea Co., Ltd., which opened in the first quarter of 2006.”

“We changed the names of our operating entities in the U.S. and Canada to incorporate the RBC Life Sciences brand. In addition the Board of Directors will recommend that the shareholders approve changing the name of the parent company from Royal BodyCare, Inc. to RBC Life Sciences, Inc. at the next annual shareholders’ meeting, scheduled for June 1, 2006.”

International Expansion

RBC began significant sales to new licensees in France, South Africa, and Saudi Arabia. In addition, the Company’s largest licensee expanded sales of RBC products into several countries in Eastern Europe in accordance with the terms of the license agreement.

The Company

RBC formulates, manufactures, and markets a research-based line of quality-controlled nutritional supplements and skin care products in compliance with GMP standards. We sell directly through independent distributors in North America, and through licensees in over 20 other countries, from our Las Colinas headquarters in Irving, Texas, and from branch offices in Vancouver, BC, Canada and Seoul Korea.

MPM Medical, Inc.

MPM Medical, a wholly owned subsidiary of RBC, develops and markets a proprietary line of research-based wound care products sold over-the-counter and by prescription through drug wholesalers, hospitals, clinics, cancer centers and nursing homes.

The following information was filed by Rbc Life Sciences, Inc. (RBCL) on Friday, March 10, 2006 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Rbc Life Sciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Rbc Life Sciences, Inc..


Never Miss A New SEC Filing Again

Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.


We Highlighted This SEC Filing For You

SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.


Widen Your SEC Filing Reading Experience

Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view


Uncover Actionable Information Inside SEC Filings

SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q


Adobe PDF, Microsoft Word and Excel Downloads

Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis


FREE Financial Statements

Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator

Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not


Financial Stability Report

Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity


Get a Better Picture of a Company's Performance

Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years


Log in with your credentials


Forgot your details?

Create Account